|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Prenyltransferase
|
 |
|
Title:
|
 |
Protein farnesyltransferase complex with farnesyl diphosphate
|
|
Structure:
|
 |
Protein farnesyltransferase. Chain: b. Synonym: ftase. Engineered: yes. Other_details: purified recombinant ftase was treated with protease gluc prior to crystallization. Protein farnesyltransferase. Chain: a. Synonym: ftase.
|
|
Source:
|
 |
Rattus norvegicus. Norway rat. Organism_taxid: 10116. Gene: fnta, fntb. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Expression_system_cell_line: high five (invitrogen). Other_details: viral expression constructs were provided by m. S. Brown and j. L. Goldstein (southwestern medical center, dallas, tx).
|
|
Biol. unit:
|
 |
Hetero-Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.75Å
|
R-factor:
|
0.240
|
R-free:
|
0.300
|
|
|
Authors:
|
 |
P.Dunten,U.Kammlott,R.Crowther,D.Weber,R.Palermo,J.Birktoft
|
|
Key ref:
|
 |
P.Dunten
et al.
(1998).
Protein farnesyltransferase: structure and implications for substrate binding.
Biochemistry,
37,
7907-7912.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Jul-98
|
Release date:
|
08-Jun-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains B, A:
E.C.2.5.1.58
- protein farnesyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-cysteinyl-[protein] + (2E,6E)-farnesyl diphosphate = S-(2E,6E)- farnesyl-L-cysteinyl-[protein] + diphosphate
|
 |
 |
 |
 |
 |
L-cysteinyl-[protein]
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
(2E,6E)-farnesyl diphosphate
|
=
|
S-(2E,6E)- farnesyl-L-cysteinyl-[protein]
Bound ligand (Het Group name = )
matches with 55.56% similarity
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Mg(2+); Zn(2+)
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chain A:
E.C.2.5.1.59
- protein geranylgeranyltransferase type I.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
geranylgeranyl diphosphate + L-cysteinyl-[protein] = S-geranylgeranyl-L- cysteinyl-[protein] + diphosphate
|
 |
 |
 |
 |
 |
geranylgeranyl diphosphate
Bound ligand (Het Group name = )
matches with 82.76% similarity
|
+
|
L-cysteinyl-[protein]
|
=
|
S-geranylgeranyl-L- cysteinyl-[protein]
Bound ligand (Het Group name = )
matches with 55.56% similarity
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
37:7907-7912
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
Protein farnesyltransferase: structure and implications for substrate binding.
|
|
P.Dunten,
U.Kammlott,
R.Crowther,
D.Weber,
R.Palermo,
J.Birktoft.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The rat protein farnesyltransferase crystal structure has been solved by
multiple isomorphous replacement methods at a resolution of 2.75 A. The
three-dimensional structure, together with recent data on the effects of several
mutations, led us to propose a model for substrate binding which differs from
the model presented by Park et al. based on their independent structure
determination [Park, H. -W., Boduluri, S. R., Moomaw, J. F., Casey, P. J., and
Beese, L. S. (1997) Science 275, 1800-1804]. Both farnesyl diphosphate and
peptide substrates can be accommodated in the hydrophobic active-site barrel,
with the sole charged residue inside the barrel, Arg202 of the beta-subunit,
forming a salt bridge with the negatively charged carboxy terminus of peptide
substrates. Our proposals are based in part on the observation of electron
density in the active site which can be modeled as bound farnesyl diphosphate
carried through the enzyme purification. In addition, our model explains in
structural terms the results of mutational studies which have identified several
residues critical for substrate specificity and catalysis.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.F.Sousa,
P.A.Fernandes,
and
M.J.Ramos
(2009).
The search for the mechanism of the reaction catalyzed by farnesyltransferase.
|
| |
Chemistry,
15,
4243-4247.
|
 |
|
|
|
|
 |
T.Subramanian,
S.Liu,
J.M.Troutman,
D.A.Andres,
and
H.P.Spielmann
(2008).
Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.
|
| |
Chembiochem,
9,
2872-2882.
|
 |
|
|
|
|
 |
G.Cui,
and
K.M.Merz
(2007).
Computational studies of the farnesyltransferase ternary complex part II: the conformational activation of farnesyldiphosphate.
|
| |
Biochemistry,
46,
12375-12381.
|
 |
|
|
|
|
 |
G.R.Labadie,
R.Viswanathan,
and
C.D.Poulter
(2007).
Farnesyl diphosphate analogues with omega-bioorthogonal azide and alkyne functional groups for protein farnesyl transferase-catalyzed ligation reactions.
|
| |
J Org Chem,
72,
9291-9297.
|
 |
|
|
|
|
 |
J.Penner-Hahn
(2007).
Zinc-promoted alkyl transfer: a new role for zinc.
|
| |
Curr Opin Chem Biol,
11,
166-171.
|
 |
|
|
|
|
 |
S.F.Sousa,
P.A.Fernandes,
and
M.J.Ramos
(2007).
Theoretical studies on farnesyltransferase: the distances paradox explained.
|
| |
Proteins,
66,
205-218.
|
 |
|
|
|
|
 |
G.Cui,
B.Wang,
and
K.M.Merz
(2005).
Computational studies of the farnesyltransferase ternary complex part I: substrate binding.
|
| |
Biochemistry,
44,
16513-16523.
|
 |
|
|
|
|
 |
R.T.Eastman,
J.White,
O.Hucke,
K.Bauer,
K.Yokoyama,
L.Nallan,
D.Chakrabarti,
C.L.Verlinde,
M.H.Gelb,
P.K.Rathod,
and
W.C.Van Voorhis
(2005).
Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum.
|
| |
J Biol Chem,
280,
13554-13559.
|
 |
|
|
|
|
 |
S.F.Sousa,
P.A.Fernandes,
and
M.J.Ramos
(2005).
Farnesyltransferase--new insights into the zinc-coordination sphere paradigm: evidence for a carboxylate-shift mechanism.
|
| |
Biophys J,
88,
483-494.
|
 |
|
|
|
|
 |
S.F.Sousa,
P.A.Fernandes,
and
M.J.Ramos
(2005).
Unraveling the mechanism of the farnesyltransferase enzyme.
|
| |
J Biol Inorg Chem,
10,
3.
|
 |
|
|
|
|
 |
W.C.Guida,
A.D.Hamilton,
J.W.Crotty,
and
S.M.Sebti
(2005).
Protein farnesyltransferase: flexible docking studies on inhibitors using computational modeling.
|
| |
J Comput Aided Mol Des,
19,
871-885.
|
 |
|
|
|
|
 |
J.S.Pickett,
K.E.Bowers,
and
C.A.Fierke
(2003).
Mutagenesis studies of protein farnesyltransferase implicate aspartate beta 352 as a magnesium ligand.
|
| |
J Biol Chem,
278,
51243-51250.
|
 |
|
|
|
|
 |
J.S.Taylor,
T.S.Reid,
K.L.Terry,
P.J.Casey,
and
L.S.Beese
(2003).
Structure of mammalian protein geranylgeranyltransferase type-I.
|
| |
EMBO J,
22,
5963-5974.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.N.Cho,
and
K.I.Lee
(2002).
Chemistry and biology of Ras farnesyltransferase.
|
| |
Arch Pharm Res,
25,
759-769.
|
 |
|
|
|
|
 |
K.E.Hightower,
P.J.Casey,
and
C.A.Fierke
(2001).
Farnesylation of nonpeptidic thiol compounds by protein farnesyltransferase.
|
| |
Biochemistry,
40,
1002-1010.
|
 |
|
|
|
|
 |
G.C.Prendergast,
and
A.Oliff
(2000).
Farnesyltransferase inhibitors: antineoplastic properties, mechanisms of action, and clinical prospects.
|
| |
Semin Cancer Biol,
10,
443-452.
|
 |
|
|
|
|
 |
H.Zhang,
M.C.Seabra,
and
J.Deisenhofer
(2000).
Crystal structure of Rab geranylgeranyltransferase at 2.0 A resolution.
|
| |
Structure,
8,
241-251.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.B.Long,
P.J.Casey,
and
L.S.Beese
(2000).
The basis for K-Ras4B binding specificity to protein farnesyltransferase revealed by 2 A resolution ternary complex structures.
|
| |
Structure,
8,
209-222.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.P.Pang,
K.Xu,
J.E.Yazal,
and
F.G.Prendergas
(2000).
Successful molecular dynamics simulation of the zinc-bound farnesyltransferase using the cationic dummy atom approach.
|
| |
Protein Sci,
9,
1857-1865.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Oliff
(1999).
Farnesyltransferase inhibitors: targeting the molecular basis of cancer.
|
| |
Biochim Biophys Acta,
1423,
C19-C30.
|
 |
|
|
|
|
 |
K.Alexandrov,
I.Simon,
V.Yurchenko,
A.Iakovenko,
E.Rostkova,
A.J.Scheidig,
and
R.S.Goody
(1999).
Characterization of the ternary complex between Rab7, REP-1 and Rab geranylgeranyl transferase.
|
| |
Eur J Biochem,
265,
160-170.
|
 |
|
|
|
|
 |
K.Del Villar,
J.Urano,
L.Guo,
and
F.Tamanoi
(1999).
A mutant form of human protein farnesyltransferase exhibits increased resistance to farnesyltransferase inhibitors.
|
| |
J Biol Chem,
274,
27010-27017.
|
 |
|
|
|
|
 |
K.E.Hightower,
and
C.A.Fierke
(1999).
Zinc-catalyzed sulfur alkyation:insights from protein farnesyltransferase.
|
| |
Curr Opin Chem Biol,
3,
176-181.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |